Review
Version 1
Preserved in Portico This version is not peer-reviewed
GRK5KO Mouse Mirrors Mild Cognitive Impairment due to Alzheimer’s Disease
Version 1
: Received: 11 April 2024 / Approved: 11 April 2024 / Online: 12 April 2024 (08:03:02 CEST)
How to cite: Suo, W. Z. GRK5KO Mouse Mirrors Mild Cognitive Impairment due to Alzheimer’s Disease. Preprints 2024, 2024040829. https://doi.org/10.20944/preprints202404.0829.v1 Suo, W. Z. GRK5KO Mouse Mirrors Mild Cognitive Impairment due to Alzheimer’s Disease. Preprints 2024, 2024040829. https://doi.org/10.20944/preprints202404.0829.v1
Abstract
Alzheimer’s disease (AD) poses a significant public health challenge due to its irreversible and progressive nature while lack of a cure. As a potential strategy to combat AD, its prevention becomes increasingly attractive. Mild Cognitive Impairment due to AD (MCI-AD) represents a critical transitional stage between normal age-related cognitive decline and more severe AD conditions, occurring just before dementia onset. Unfortunately, there is currently no established animal model that accurately recapitulates MCI-AD characteristics. While many laboratories have traditionally used normally aged wild-type animals as experimental models, this approach falls short in representing the inherently worse state of MCI-AD compared to normal aging. To address this gap, we introduce an animal model—a transgenic mouse line with genetic inactivation of G protein-coupled receptor kinase-5 (GRK5), commonly known as the GRK5 knockout (GRK5KO) mouse. These GRK5KO mice exhibit amnesia, cognitive deficits, increased β-amyloid levels, neurofibrillary tangle (NFT) immunopositive axonopathy, and hippocampal neurodegenerative changes. Importantly, these pathological alterations predominantly impact the entorhinal, transentorhinal, and hippocampal cortices, aligning with human MCI-AD criteria and Braak stage II of human AD progression. Notably, female GRK5KO mice show approximately 2.5 times more NFT-positive axonopathy than males, mirroring the higher prevalence of AD cases in women. Collectively, existing data strongly supports the GRK5KO mouse as a qualified animal model for studying MCI-AD.
Keywords
Alzheimer’s disease; Mild cognitive impairment due to Alzheimer’s disease; aging; animal model; GRK5 deficiency; GRK5 knockout mouse.
Subject
Biology and Life Sciences, Neuroscience and Neurology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment